E3 ubiquitin ligases: styles, structures and functions

被引:181
|
作者
Yang, Quan [2 ]
Zhao, Jinyao [2 ]
Chen, Dan [1 ]
Wang, Yang [2 ]
机构
[1] Dalian Med Univ, Affiliated Hosp 1, Dept Pathol, Dalian 116044, Peoples R China
[2] Dalian Med Univ, Inst Canc Stem Cell, Affiliated Hosp 2, Dalian 116044, Peoples R China
来源
MOLECULAR BIOMEDICINE | 2021年 / 2卷 / 01期
基金
中国国家自然科学基金;
关键词
E3; ligases; Ubiquitination; 26S proteasome degradation; Cancer progression; Therapeutics; PROTACs; IN-VIVO; PROTEIN KNOCKDOWN; PROTEASOME-SYSTEM; MDM2; ANTAGONISTS; CELL-SURVIVAL; HECT FAMILY; DNA-DAMAGE; C2; DOMAIN; CANCER; P53;
D O I
10.1186/s43556-021-00043-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
E3 ubiquitin ligases are a large family of enzymes that join in a three-enzyme ubiquitination cascade together with ubiquitin activating enzyme E1 and ubiquitin conjugating enzyme E2. E3 ubiquitin ligases play an essential role in catalyzing the ubiquitination process and transferring ubiquitin protein to attach the lysine site of targeted substrates. Importantly, ubiquitination modification is involved in almost all life activities of eukaryotes. Thus, E3 ligases might be involved in regulating various biological processes and cellular responses to stress signal associated with cancer development. Thanks to their multi-functions, E3 ligases can be a promising target of cancer therapy. A deeper understanding of the regulatory mechanisms of E3 ligases in tumorigenesis will help to find new prognostic markers and accelerate the growth of anticancer therapeutic approaches. In general, we mainly introduce the classifications of E3 ligases and their important roles in cancer progression and therapeutic functions.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] Editorial: E3 Ubiquitin Ligases: From Structure to Physiology
    Licchesi, Julien D. F.
    Laman, Heike
    Ikeda, Fumiyo
    Bolanos-Garcia, Victor M.
    FRONTIERS IN PHYSIOLOGY, 2020, 11
  • [42] The role of E3 ubiquitin ligases in the development and progression of glioblastoma
    Luke M. Humphreys
    Paul Smith
    Zhuoyao Chen
    Shahd Fouad
    Vincenzo D’Angiolella
    Cell Death & Differentiation, 2021, 28 : 522 - 537
  • [43] E3 ubiquitin ligases in the acute leukemic signaling pathways
    Zhan, Qianru
    Zhang, Heyang
    Wu, Boquan
    Zhang, Naijin
    Zhang, Lijun
    FRONTIERS IN PHYSIOLOGY, 2022, 13
  • [44] Target recognition by membrane E3 ubiquitin ligases.
    Arines, F. M.
    Hamlin, A. J.
    Bulinski, P. J.
    Li, M.
    MOLECULAR BIOLOGY OF THE CELL, 2018, 29 (26)
  • [45] The Cullin-ROC family of E3 Ubiquitin Ligases
    Xiong, Yue
    FASEB JOURNAL, 2008, 22
  • [46] Novel role for E3 ubiquitin ligases in protein degradation
    Nacusi, LP
    Gibbons, R
    Wang, W
    Liu, XD
    Sheaff, RJ
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (11) : 2685S - 2685S
  • [47] E3 ubiquitin ligases in ErbB receptor quantity control
    Carraway, Kermit L., III
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2010, 21 (09) : 936 - 943
  • [48] Progress on Poxvirus E3 Ubiquitin Ligases and Adaptor Proteins
    Cui, Haoran
    Zhang, Yaxian
    Zhang, Leiliang
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [49] Ubiquibodies: Engineered E3 Ubiquitin Ligases for Targeted Degradation
    Stephens, Erin A.
    Portnoff, Alyse D.
    Baltz, Morgan R.
    Varner, Jeffrey D.
    DeLisa, Matthew P.
    PROTEIN SCIENCE, 2014, 23 : 155 - 155
  • [50] TRIM E3 Ubiquitin Ligases in Rare Genetic Disorders
    Meroni, Germana
    PROTEOSTASIS AND DISEASE: FROM BASIC MECHANISMS TO CLINICS, 2020, 1233 : 311 - 325